2nd Quarter - Report

MERCK & CO, INC. for MERCK & CO INC

Firm
Client
Income
—
Expenses
$1,170,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Support amendments to patent reform legislation (S. 1145, H.R. 1908).

LobbyistCovered position, as disclosed
LAURIE MICHEL —

Contacted: U.S. Trade Representative (USTR); SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1145 (110th), H.R. 1908 (110th)

Budget/Appropriations BUD

Support increased funding for CDC's National Immunization Program (Sec. 317 Program) (FY 09 Budget and Labor-HHS Appropriations bills). Support increased funding for FDA (FY 09 Agriculture Appropriations bill).

LobbyistCovered position, as disclosed
ANNE ESPOSITO —
LAURIE MICHEL —

Contacted: SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Trade (domestic/foreign) TRD

Educate members of Congress, USTR on compulsory licenses in Thailand and Brazil (no specific legislation). Support intellectual property protections in trade negotiations (Columbia, Korea FTAs).

LobbyistCovered position, as disclosed
TOM BOMBELLES —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Health Issues HCR

Oppose efforts to permit RX drug importation into U.S., other than by drug's manufacturer (no specific bill). Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill). Support efforts to promote public/private partnerships for comparative effectiveness assessment (no specific legislation). Support demonstration projects to assess the short-term and long-term effectiveness of obesity management programs (no specific bill). Support congressional interest in obesity awareness efforts (no specific bill).

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
ERIN DARLING —
ANNE ESPOSITO —
JANE HORVATH —
LAURIE MICHEL —
PETER RUBIN —
IAN SPATZ —
JASON BENJAMIN VAN PELT —

Contacted: U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill). Support coverage of preventive services in Medicare (H.R. 6331).

LobbyistCovered position, as disclosed
VICTORIA BLATTER —
ANNE ESPOSITO —
JANE HORVATH —
LAURIE MICHEL —
PETER RUBIN —
JASON BENJAMIN VAN PELT —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; U.S. Trade Representative (USTR)

Bills named: S. 250 (110th), H.R. 6331 (110th), H.R. 4 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.